Gut Microbiota at the Crossroad of Hepatic Oxidative Stress and MASLD
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent chronic liver condition marked by excessive lipid accumulation in hepatic tissue. This disorder can lead to a range of pathological outcomes, including metabolic dysfunction-associated steatohepatitis (MASH) and cirrhosi...
Saved in:
Main Authors: | Fabrizio Termite, Sebastiano Archilei, Francesca D’Ambrosio, Lucrezia Petrucci, Nicholas Viceconti, Roberta Iaccarino, Antonio Liguori, Antonio Gasbarrini, Luca Miele |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/14/1/56 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bile Acids and Their Value for Central Nervous System
by: Yu. O. Shulpekova, et al.
Published: (2022-01-01) -
INVESTIGATING CHOLAGOGUE AND CHOLERETIC ACTIVITY OF PEUMUS BOLDUS
by: Raphael S. F. Silva, et al.
Published: (2025-01-01) -
Effect of a Ketogenic Diet on Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) Progression: A Randomized Controlled Trial
by: Sakkarin Chirapongsathorn, et al.
Published: (2025-01-01) -
FXR activation reduces the formation of macrophage foam cells and atherosclerotic plaque, possibly by down regulating hepatic lipase in macrophages
by: Qiang Gu, et al.
Published: (2025-02-01) -
Development and validation of machine learning models for MASLD: based on multiple potential screening indicators
by: Hao Chen, et al.
Published: (2025-01-01)